{"entity":{"type":"insider","cik":"0001890784","url":"/insider/0001890784","json_url":"/insider/0001890784.json","name":"Anand Bhaskar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":6,"first":"2023-03-06","last":"2023-09-07","span_basis":"filed_date"},"name_variants":[{"name":"Anand Bhaskar","source":"filing","n_filings":6,"first_seen":"2023-03-06","last_seen":"2023-09-07"}],"transactions":[{"id":7899347,"accession":"0001209191-23-048601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048601","line_url":"/filing/0001209191-23-048601#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":406.0,"shares_display":"406","price_per_share":169.2,"price_display":"169.20","price_state":"stated","total_value":68695.2,"total_display":"68,695.20","total_whole":"68,695","shares_owned_after":24089.0,"shares_owned_after_display":"24,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"},{"id":7923107,"accession":"0001209191-23-046276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-046276","line_url":"/filing/0001209191-23-046276#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":168.4184,"price_display":"168.42","price_state":"stated","total_value":35367.864,"total_display":"35,367.86","total_whole":"35,368","shares_owned_after":24495.0,"shares_owned_after_display":"24,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":7923104,"accession":"0001209191-23-046276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046276","line_url":"/filing/0001209191-23-046276#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":193.0,"shares_display":"193","price_per_share":169.055,"price_display":"169.06","price_state":"stated","total_value":32627.615,"total_display":"32,627.62","total_whole":"32,628","shares_owned_after":24705.0,"shares_owned_after_display":"24,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider"},{"id":8581971,"accession":"0001209191-23-037802","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037802","line_url":"/filing/0001209191-23-037802#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2343.0,"shares_display":"2,343","price_per_share":102.1118,"price_display":"102.11","price_state":"stated","total_value":239247.9474,"total_display":"239,247.95","total_whole":"239,248","shares_owned_after":24898.0,"shares_owned_after_display":"24,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-16","scope":"insider"},{"id":8438629,"accession":"0001209191-23-030181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030181","line_url":"/filing/0001209191-23-030181#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":81.1038,"price_display":"81.10","price_state":"stated","total_value":11030.1168,"total_display":"11,030.12","total_whole":"11,030","shares_owned_after":25679.0,"shares_owned_after_display":"25,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8438623,"accession":"0001209191-23-030181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030181","line_url":"/filing/0001209191-23-030181#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":85.9833,"price_display":"85.98","price_state":"stated","total_value":81684.135,"total_display":"81,684.14","total_whole":"81,684","shares_owned_after":25815.0,"shares_owned_after_display":"25,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":7810393,"accession":"0001209191-23-017248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-017248","line_url":"/filing/0001209191-23-017248#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165.0,"shares_display":"165","price_per_share":84.58,"price_display":"84.58","price_state":"stated","total_value":13955.7,"total_display":"13,955.70","total_whole":"13,956","shares_owned_after":26765.0,"shares_owned_after_display":"26,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8019274,"accession":"0001209191-23-016281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016281","line_url":"/filing/0001209191-23-016281#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001890784","owner_name":"Anand Bhaskar","owner_display_name":"Anand Bhaskar","owner_url":"/insider/0001890784","role":"Officer (SVP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":820.0,"shares_display":"820","price_per_share":87.47,"price_display":"87.47","price_state":"stated","total_value":71725.4,"total_display":"71,725.40","total_whole":"71,725","shares_owned_after":26930.0,"shares_owned_after_display":"26,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (SVP, Chief Accounting Officer)","n_filings":6,"first_seen":"2023-03-06","last_seen":"2023-09-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001890784","retrieved_at":"2026-08-22T16:01:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}